|
Division of
Cardiovascular Medicine
Agarwal N, You H, Liu Y,
Chiriva-Internati M, Bremner J, Garg T, Grizzi F, Krishna Prasad
C, Mehta JL, Hermonat PL.
Generation of recombinant skin in vitro by adeno associated
virus type 2 vector transduction. Tissue Engineering
2004; 10:1707-15.
Amani F,
Smith ES.
Atrial fibrillation: rate versus rhythm control. J Ark Med Soc
2005;102:110-2.
Aude YW,
Mehta JL. Do we need continuous ECG monitoring in patients transferred for
primary angioplasty? (Editorial) European Heart Journal
2005;27:249-50.
Aude YW,
Lamas GA, Lopez-Jimenez F, Lieberman EH, Almon M, Hansen M,
Rojas G, Agatston AS, Hennekens CH. A randomized trial comparing
the National Cholesterol Education Program Step 2 Diet to a diet
lower in carbohydrates and higher in protein and monounsaturated
fat (The South Beach Diet Study). Arch Intern Med 2004;
164:2141-6.
Aude YW, Mego P,
Mehta JL. Metabolic syndrome:
dietary interventions. Current Opinion in Cardiology
2004; 19:473-9.
Bagwe
S, Sachdeva R, Mehta JL.
High-risk acute coronary syndrome patient and cardiac biomarkers
in the emergency department: where do we stand? Eur Heart J
2007; 28(9):1043-4. Editorial.
Bansal D, Chahoud G, Ison
K, Gupta E, Montgomery M, Garza L,
Mehta JL.
Pleuropericarditis and pericardial tamponade associated with
inflammatory bowel disease. Journal of the Arkansas Medical
Society 2005;102:16-9.
Bansal D,
Gaddam V, Aude YW, Bissett J,
Fahdi I, Garza L, Joseph J,
Molavi B, Pai BV,
Sinha A, Smith ES, Mehta JL.
Trends in the care of patients with acute myocardial infarction
at a university-affiliated VA medical center. Journal of
Cardiovascular Pharmacology and Therapeutics 2005; 10:
39-44.
Bansal
D, Chahoud G, Smith ES, Mehta JL. Prevention of heart failure. Curr Opin Cardiol 2006;21(5):510-6.
Bansal D, Chahoud G and
Mehta JL. Heart failure
prevention. Current Opinion in Cardiology 2006;
21(5):510-6.
Bansal D,
Eigenbrodt M, Gupta E, Mehta JL. Traditional
risk
factors and acute myocardial infarction in patients hospitalized
with cocaine-associated chest pain. Clin Cardiol 2007;
5;30(6):290-294.
Bloomfield HE, Nelson DB, van Ryn M, Neil BJ, Koets NJ,
Basile JN, Samaha FE, Kaul R, Mehta JL,
Bouland D. A trial of education, prompts, and opinion leaders to
improve prescription of lipid modifying therapy by primary care
physicians for patients with ischemic heart disease. Quality
and Safety in Health Care 2005; 14:258-63.
Boucher A, Lu D, Burgess SC,
Télémaque-Potts S, Jensen
MV, Mulder H, Wang MY, Unger RH, Sherry AD and Newgard CB.
Biochemical mechanism of lipid-induced impairment of
glucose-stimulated insulin secretion and reversal with a malate
analogue. J Biol Chem 2004; 279:27263-71.
Brenner
B, Harney JT, Ahmed BA, Jeffus BC, Unal R, Mehta JL, Kilic F. Plasma serotonin levels and the platelet serotonin
transporter. J Neurochem 2007; 102(1)206-15.
Burrows DR,
Smith ES. Pericarditis: guidelines and management.
J
Ark Med Soc 2006;103(4):89-90.
Camp TM, Aru GM, Hayden MR,
Mehta JL, Tyagi SC.
Doxycycline ameliorates ischemic and border-zone remodeling and
endothelial dysfunction after myocardial infarction in rats.
Journal of Heart and Lung Transplantation 2004; 23:729-36.
Chahoud G, Aude YW, Mehta JL.
Dietary Recommendations in the Prevention and Treatment of
Coronary Heart Disease: Do We Have the Ideal Diet Yet?. Am J
Cardiol 2004; 94:1260-7.
Chahoud G, Mehta JL. Heparin
induced thrombocytopenia and thrombosis. Clinical Cardiology
2004; 27:514Chen J, Li D; Schafer R, Mehta JL.
Cross-talk between dyslipidemia and renin-angiotensin system and
the role of lox-1 and MAPK in atherogenesis: Studies with the
combined use of rosuvastatin and candesartan. Atherosclerosis
2006;184(2):295-301.
Chen J, Mehta JL, Haider N,
Zhang X, Narula J, Li D. Role of caspases in ox-LDL-Induced
apoptotic cascade in human coronary artery endothelial cells.
Circulation Research 2004: 94:370-6.
Chen J, Mehta JL. Role of
oxidative stress in coronary heart disease. Indian Heart
Journal 2004; 56:163-73.
Chen J, Li D, Schaefer RF,
Mehta JL. Inhibitory effect of
candesartan and rosuvastatin on CD40 and MMPs expression in
Apo-E knockout mice: Novel insights into the role of RAS and
dyslipidemia in atherogenesis. Journal of Cardiovascular
Pharmacology 2004; 44:446-52.
Chen J, Li D, Zhang X, Mehta JL.
TNF-?-induced apoptosis of human coronary artery endothelial
cells: modulation by the PPAR-? ligand pioglitazone. Journal
of Cardiovascular Pharmacology and Therapeutics 2004;
9:35-41.
Chen J, Li D; Schafer R,
Mehta JL. Cross-talk between
dyslipidemia and renin-angiotensin system and the role of lox-1
and MAPK in atherogenesis: Studies with the combined use of
rosuvastatin and candesartan. Atherosclerosis 2005;
184(2):295-301.
Chen J, Liu H, Hermonat PL,
Mehta JL. Molecular Dissection of Human LOX-1
Promoter: Nucleotides and Transcription Factors Requirement
During Transactivation. Journal of the American College of
Cardiology 2006;47:340A.
Chen J, Liu H, Liu Y, Hermonat PL,
Mehta JL. Combination of aspirin and Pravastatin dramatically
reduces oxidative stress and the expression of
LOX-1 and adhesion molecules: Novel insight into the mechanism
of action of aspirin and statins. Journal of the American
College of Cardiology 2006;47:340A.
Chen J, Liu Y, Liu H, Hermonat PL,
Mehta JL. Oxidized-LDL receptor LOX-1 transcriptional
regulation by Oct-1 in human endothelial cells: Implications
for atherosclerosis.
Biochemical Journal 2006;393: 255-65.
Chen J,
Mehta JL.
Interaction of oxidized low-density lipoprotein and the
renin-angiotensin system in coronary artery disease. Current
Hypertension Reports. 2006;8:139-43.
Chen J,
Mehta JL. Angiotensin II-mediated oxidative stress and
procollagen-1 expression in cardiac fibroblasts: blockade by
pravastatin and pioglitazone. AJ Physiol: Heart Circ Physiol
2006;291(4):H1738-45.
Chen K, Chen J, Li D, Zhang X, Mehta JL.
Angiotensin II regulation of collagen type-I expression in
cardiac fibroblasts: Modulation by the PPAR-? Ligand
Pioglitazone. Hypertension 2004; 44:1-7.
Chen K, Li D, Zhang X, Hermonat PL,
Mehta JL. Anoxia-reoxygenation stimulates collagen
type-I and MMP-1 expression in cardiac fibroblasts: Modulation
by the PPAR-? ligand pioglitazone. Journal of Cardiovascular
Pharmacology 2004; 44:682-7.
Chen K, Mehta JL, Li D,
Joseph L, Joseph J. The TGF-? receptor endoglin is expressed in
cardiac fibroblasts pro-fibrogenic actions of angiotensin II.
Circulation Research 2004; 95:1167-73.Chen K, Liu Y, Chen J, Li D,
Hermonat PL, Sawamura T,
Mehta JL. Adhesion molecule expression in
fibroblasts: Alteration in fibroblast biology following
transfection with LOX-1 plasmids. Hypertension
2005;46:622-7.
Chen X, Zhang X, Kubo H, Harris DM, Mills GD, Moyer J,
Berretta R, Télémaque-Potts S, Marsh JD
and Houser SR. Ca2+ Influx-induced sarcoplasmic reticulum Ca2+
overload causes mitochondrial-dependent apoptosis in ventricular
myocytes. Circ Res 2005;97:1009-17.
Chiriva-Internati M, Grizzi F, Jumper CA, Cobos E,
Hermonat PL, Frezza EE.
Immunological treatment of liver tumors. World J
Gastroenterol 2005; 14(11):6571-6.
Cola C, R Almeida M, Li D,
Romeo F, Mehta JL. Regulatory
role of endothelium in the expression of genes affecting
arterial calcification. Biochemical Biophysical Research
Communications 2004; 320:424-7.
Dandapat
A, Chen J, Hu CP, Liu Y, Li D, Thomas M,
Hermonat PL, Sawamura,
Mehta JL. LOX-1 ablation reduces atherosclerosis. American Heart
Association Scientific Sessions 2006 Annual Meeting, November
12-15, Chicago, IL. Circ 2006; 114: II-254a.
Dandapat A, Liu Y, Chen J, Hu CP,
Li D, Hermonat PL, Mehta JL. Delivery of angiotensin II type 2
receptor cDNA with adeno-associated virus type 2 by intravenous
route decreases atherosclerosis in the LDLR knockout mice fed
with high cholesterol diet. American Heart Association
Scientific Sessions 2006 Annual Meeting, November 12-15,
Chicago, IL. Circ 2006; 114: II-214a.
Darpan BD, Gaddam V,
Aude YW, Bissett J, Fahdi I, Garza L,
Joseph J, Molavi B, Pai B,
Sinha A, Smith E, Mehta JL.
Trends in the care of patients with acute myocardial infarction
at a University-affiliated VA Medical Center. J Cardiovasc
Pharmacol Therapeut 2005; 10:39-44.
De Las Casas L E, Gokden M, Mukunyadzi, White P, Baker S J,
Hermonat P L, Hong Y, Korourian
S, Malka S F, Miranda R N. “A morphologic and statistical
comparative study of small cell carcinoma and non-Hodgkin’s
lymphoma in fine needle aspiration biopsy material from lymph
nodes. Diagnostic Cytopathology 31: 229-234, 2004.
De Las Casas LE, Gokden M, Baker SJ, Korourian S,
Hermonat PL, You H, Miranda RN,
Shalkham JE, O'Brien LA, Mukunyadzi P. Malignant melanoma
metastatic to the liver. A cytomorphologic comparative study to
identify reproducible diagnostic criteria. Acta Cytol
2004; 48:32-8.
De S, Sharma R, Trigwell S, Laska B, Ali N, Mazumder MK,
Mehta JL.
Plasma treatment of polyurethane coatings for improved
endothelial cell growth and adhesion. Journal of Biomaterials
Science, Polymer Edition, 2005;16: 973-989.
Eigenbrodt M, Bursac Z, Eigenbrodt
EP, Couper DJ, Trace RE, Mehta JL. Mathematical estimation of
the potential effect of vascular remodeling/ectasia on B-mode
ultrasound intima-media thickness. Quarterly Journal of
Medicine 2004; 97:729-37.
Eigenbrodt ML, Bursac
Z, Rose KM, Couper DJ, Tracy RE, Evans GW, Brancati F,
Mehta JL.
Common carotid arterial (CCA) interadventitial distance
(diameter) as an indicator of the damaging effects of age and
atherosclerosis, a cross-sectional study of the Atherosclerosis
Risk in Community Cohort Limited Access Data (ARICLAD),
1987-89. Cardiovascular Ultrasound. 2006;4:1.
Eigenbrodt
ML, Sukhija R, Rose KM, Tracy RE, Couper DJ, Evans GW,
Bursac Z, Mehta JL. Common carotid artery wall thickness
and external diameter as predictors of prevalent and incident
cardiac events in a large population study. Cardiovasc
Ultrasound 2007;5:11.
Fahdi IE, Gaddam V, Saucedo JF, Kishan CV, Vyas K, Deneke MG et
al. Bradycardia during therapy for multiple myeloma with
thalidomide. American Journal of Cardiology 2004;
93(8):1052-1055.
Fahdi IE,
Molavi B, Mehta JL. The ratio of triglyceride to
high-density lipoprotein is an independent risk factor for
angiographic coronary atherosclerosis in patients with metabolic
syndrome. Circulation 2004; 25: 109:16(P77).
Fahdi IE, Saucedo JF, Hennebry T, Ghani M, Sadanandan S,
Garza
L. Incidence and time course of thrombocytopenia with abciximab
and eptifibatide in patients undergoing percutaneous coronary
intervention. American Journal of Cardiology 2004;
93:453-455.
Fan QI,
Vanderpool KM, Chung H-S, Marsh JD.
The L-type calcium channel alpha 1C subunit undergoes
extensive, uncoordinated alternative splicing. Mol Cell
Biochem 2005; 269(1-2); 153-63.
Golden KL,
Marsh JD, Jiang Y, Moulden J.
Gonadectomy alters myosin heavy chain composition in isolated
cardiac myocytes. Endocrine 2004; 24(2):137-40.
Golden KL,
Marsh JD, Jiang Y. Testosterone
regulates mRNA levels of calcium regulatory proteins in cardiac
myocytes. Horm Metab Res 2004; 36(4): 197-202.
Golden KL, Marsh JD, Jiang
Y, Moulden J.
Acute actions of testosterone on contractile function of
isolated rat ventricular myocytes. Eur J Endocrinol;
152(3):470-83, 2005.
Grizzi F, Chiriva-Internati M, Franceschini B, Bumm K,
Colombo P, Ciccarelli M, Donetti E, Gagliano N,
Hermonat PL, Bright RK, Gioia
M, Dioguardi N, Kast WM. Sperm protein 17 is expressed in human
somatic ciliated epithelia. J Histochem Cytochem 2004;
52:549-54.
Grizzi F, Franceschini B, Hermonat PL,
Liu Y, Chiriva-Internati M. Some remarks on the somatic
expression of sperm protein 17. Int J Cancer 2004; 10
(111):972-3.
Grizzi F, Russo C, Portinaro N,
Hermonat PL, Chiriva-Internati M. Complexity and
cancer. Gastroenterology 2004; 126:630-1.
Hamilton KL, Quindry JC, French JP, Staib J, Hughes J,
Mehta JL, Powers SK. MnSOD
antisense treatment and exercise-induced protection against
arrhythmias. Free Radical Biology & Medicine 2004;
37:1360–8.
Hayes E, Mehta P, Mehta JL.
Depression in heart disease – A plea for help! (Editorial)
Indian Heart Journal 2005;57:360-3.
Hauer-Jensen M,
Fort C,
Mehta JL,
Fink LM. Influence
of statins on postoperative wound complications after inguinal
or ventral herniorrhaphy. Hernia 2006;10:48-52.
Hermonat
PL, Mehta JL. Potential of gene therapy for
myocardial ischemia. Curr Opin Cardiol 2004;19:517-23.
Hermonat PL,
You H, Chiriva-Internati CM, Liu Y. Analysis of adeno-associated
virus and HPV interaction. Methods Mol Med 2005;119:397-409.
Hermonat PL,
Li D, Yang B, Mehta JL. Mechanism of action and delivery
possibilities for TGFbeta1 in the treatment of myocardial
ischemia. Cardiovasc Res 2007;74(2):235-43.
Hermonat PL,
editor. Cancer and Gene Therapy. 2007.
Hinagata
JI, Kakutani M, Fujii T, Naruko T, Inoue N, Fujita Y,
Mehta JL,
Ueda M,
Sawamura T. Oxidized LDL receptor LOX-1 is involved in neointimal
hyperplasia after balloon arterial injury in a rat model.
Cardiovascular Research 2005;69:263-71.
Hu
CP, Chen J, Dandapat A, Li D, Liu Y,
Hermonat PL, Mehta JL.
Targeted deletion of LOX-1 ameliorates myocardial
ischemia-reperfusion injury in mice, reduces inflammation and
expression of MMPs. American Heart Association Scientific
Sessions 2006 Annual Meeting, November 12-15, Chicago, IL. Circ.
2006; 114: II-157a.
Huang H,
Wang H, Wu ZQ, You CX, Luo RC, Yong L, Hermonat PL.
Effects of two different antigen-loading methods on the
activity of dendritic cell vaccine for colorectal carcinoma cell
inhibition in vitro] Nan Fang Yi Ke Da Xue Xue Bao 2007
;27(4):492-5. Chinese.
Hughes B, Chahoud G, Mehta JL.
Aortic stenosis: Is it simply a degenerative process or an
active atherosclerotic process? (Editorial) Clinical
Cardiology 2005; 28: 111-4.
Joseph J, Rimawi A, Mehta P, Cottler-Fox M,
Sinha A, Singh BK,
Pacheco R, Smith ES, Mehta JL.
Safety and effectiveness of granulocyte-colony stimulating
factor in mobilizing stem cells and improving cytokine profile
in advanced chronic heart failure. American Journal of
Cardiology
2006;97:681-4.
Khan Q, Mehta JL.
Relevance of platelet-independent effects of aspirin in its
salutary effect in atherosclerosis-related events. Journal of
Atherosclerosis and Thrombosis 2005;12:185-90.
Khan Q,
Sachdeva R, Mehta JL. Hyperglycemia predicts failure in
percutaneous intervention of coronary chronic total occlusion.
Southern Society for Clinical Investigation meetings, New
Orleans, LA, February, 2007;50:S195a.
Lennon S, Quindry JC, Hamilton KL,
French J, Staib J, Mehta JL,
Powers SK. Loss of exercise-induced cardioprotection following
cessation of exercise. Journal of Applied Physiology 2004
96:1299-305.
Lennon S, Quindry JC, Hamilton KL, French J, Staib J,
Mehta JL, Powers SK. Elevated
MnSOD is not required for exercise-induced cardioprotection
against myocardial stunning. American Journal of Physiology
2004;287:H975-80.
Leonardi M, Bissett J. Prevention of atrial
fibrillation. Curr Opin Cardiol 2005;20:417-23.
Li D, Chen K,
Sinha N, Zhang X, Sinha AK,
Romeo F, Mehta JL. The effects of ligand
pioglitazone on platelet aggregation and arterial thrombusgPPAR-
formation.
Cardiovascular Research
2005;65:907-12.
Li D, Mehta JL.
Oxidized
LDL, a critical factor in atherogenesis. Cardiovascular
Research 2005;78:353-4.
Li D, Liu Y,
Chen J, Velchala, Amani F, Nemarkommula A, Chen K, Rayaz H,
Zhang D, Liu H, Sinha AK, Romeo F, Hermonat PL, Mehta
JL.
Suppression of atherogenesis by delivery of TGFbeta1ACT using
adeno-associated virus type 2 in LDLR knockout mice. Biochem
Biophys Res Commun 2006;344(3):701-7.
Li
H, Télémaque S, Miller RE,
Marsh JD.
High glucose inhibits apoptosis induced by serum deprivation
in vascular smooth muscle cells via upregulation of Bcl-2 and
Bc1-xl. Diabetes 54(2):540-5, 2005.
Liu Y, You H, Hermonat PL.
Studying the HPV life cycle in 3A trophoblasts and resulting
pathophysiology. Methods Mol Med 2005;119:237-45.
Liu Y, Chiriva-Internati M, You C, Luo R, You H, Prasad CK,
Grizzi F, Cobos E, Klimberg VS, Kay H,
Mehta JL, Hermonat PL. Use and
specificity of breast cancer antigen/milk protein BA46 for
generating anti-self-cytotoxic T lymphocytes by recombinant
adeno-associated virus-based gene loading of dendritic cells.
Cancer Gene Therapy 2005; 12:304-12.
Liu Y, Li D, Chen J, Xie J, Bandyopadhyay S, Zhang D,
Nemarkommula AR, Liu H, Mehta JL,
Hermonat PL. Inhibition of atherogenesis in LDLR
knockout mice by systemic delivery of adeno-associated virus
type 2-hIL-10. Atherosclerosis 2006;188(1):19-27.
Liu Y, Zhou W, You C, Zheng H, You H, Liu H, Zhang D, Luo R,
Kay HH, Hermonat PL. An
autoimmune domain-reduced HCV core gene remains effective in
stimulating anti-core cytotoxic T lymphocyte
activity. Vaccine 2006; 6;24:1615-24.
Lopez-Jimenez F, Malinski M, Gutt M,
Sierra-Johnson J, Aude YW,
Rimawi A, Mego P, Thomas R, Allison T, Kirby B, Hughes-Borst B,
Somers V. Recognition, diagnosis and management of obesity after
myocardial infarction. International Journal of Obesity
2004; 29:1-5.
Mahadevan M,
Liu Y, You C, Luo R, You H, Mehta JL, Hermonat, PL.
Generation of robust cytotoxic T lymphocytes against prostate
specific antigen by transduction of dendritic cells using
protein and recombinant adeno-associated virus. Cancer Immunol
Immunother 2007; 56(10):
1615-24.
Mango R, Biocca S, del Vecchio F, Clementi F, Sangiuolo F,
Amati F, Filareto A, Grelli S, Spitalieri P, Filesi I, Favalli
C, Lauro R, Mehta JL,
Romeo F, Novell G. A new
splicing isoform of OLR1 gene is protective against acute
myocardial infarction. Circulation Research 2005;
97:152-8.
Mango R,
Vecchione L, Raso B, Borgiani P, Brunetti E,
Mehta JL,
Lauro R,
Romeo F,
Novelli G. Pharmacogenomics in
cardiovascular disease: the role of single nucleotide
polymorphisms in improving drug therapy. Expert Opinion in
Pharmacotherapy 2005;6:2565-76.
Marsh JD.
Progress in stroke prevention and treatment. Cardiology
Rounds: Brigham and Women’s Hospital 2006; 10 (2).
Marsh JD, and (by
invitation: Telemaque S, Rhee SW,
Stimers JR, Rusch NJ). Delivery of ion channel genes to treat
cardiovascular diseases. Transactions of the American
Clinical and Climatological Association 2008; 119:171-183).
Martuscelli E, Romagnoli A, D'Eliseo
A, Tomassini M, Razzini C, Sperandio M, Simonetti G,
Romeo F, Mehta JL. Evaluation
of venous and arterial conduits patency by 16-slice spiral
computed tomography. Circulation 2004;110:3234-8
Martuscelli
E, Romagnoli A, Sardella G, Tomassini M, D’Eiseo A, Chiricolo G,
Razzini C, Sperandino M, Simonetti G, Mehta JL,
Romeo F. Thrombolysis in ST-segment elevation myocardial infarction:
potential role of thin-slice computed tomography in the
assessment of reperfusion and plaque characterization. Clin
Cardiol 2006;29(7):322.
Marwali MR,
Mehta JL. COX-2 inhibitors and cardiovascular risk. Inferences
based on biology and clinical studies. J Thromb Haemost 2006;96(4):401-6.
Marwali R,
Mohandas B, Hu CP, Chen J, Kavdia M, Cawich I, Johns A,
Knappertz V, Deonikar P, Sawamura T, Mehta JL. Reduction of
platelet LOX-1 expression by aspirin and pravastatin; mechanism
relating to nitric oxide, oxidative stress and chemokine RANTES.
American Heart Association Scientific Sessions 2006 Annual
Meeting, November 12-15, Chicago, IL. Circ 2006; 54: II-71a.
Marwali MR,
Hu C, Mohandas B, Dandapat A, Deonikar P, Chen J, Cawich I,
Tatsuya T, Kavdia M, Mehta JL. Modulation of ADP-induced
platelet activation by aspirin and pravastatin. The Journal of Pharmacol and Exp Ther 2007;
322(3).
McEwen JE, Zimniak P, Mehta JL,
Shmookler-Reis RJ. Molecular pathology of aging and its
implications for senescent coronary atherosclerosis. Current Opinion in Cardiology 2005; 20:399-406.
McFalls EO, Ward HB, Moritz TE, et al (Aude
YW, listed in Appendix) Coronary artery
revascularization prophylaxis (CARP). N Engl J Med 2004;
351:2795-804.
Mehta JL,
Chen J, Yu F, Li D. Aspirin inhibits ox-LDL-mediated LOX-1
expression and metalloproteinase-1 in human coronary endothelial
cells. Cardiovascular Research 2004; 64:243-9.
Mehta JL, Hermonat PL, Li D,
Garza L, Novelli G.
Identification and regulation of LOX-1, a receptor for Ox-LDL:
Implications in atherogenesis and myocardial ischemia. In:
Pharmacotherapy of Heart Failure, Eds S.K. Gupta, Pawan K.,
Singal, and S.S. Agrawal. New Delhi, India: Anamaya Publishers,
2005.
Mehta JL.
The role of LOX-1, a novel receptor for ox-LDL, in
atherosclerosis. Canadian Journal of Cardiology 2004;
20:32B-6B.
Mehta JL. Another round of
prevention. Current Opinion in Cardiology 2004; 19:472.
Mehta JL,
Liu Y, Chen J, Xie J, Bandyopadhyay S, Nemarkommula A, Mehta P,
Li D, Hermonat PL.
Successful gene therapy against atherosclerosis by rAAV
delivery of IL-10, Proceedings of the 12th World
Congress on Heart Disease, Vancouver, BC, July 16-19, 2005.
Mehta JL, Chen J, Hermonat
PL, Romeo F, Novelli G.
Lectin-like oxidized-low density lipoprotein receptor-1 (LOX-1):
A critical player in the development of atherosclerosis and
related disorders. Cardiovascular Research 2006;69:36-45.
Mehta JL, Rasouli N,
Sinha A,
Molavi B. Oxidative stress in diabetes: Basis of
its adverse cardiac effects. The International Journal of
Biochemistry & Cell Biology 2006;38:794-803.
Mehta JL,
Li D, Liu Y, Hermonat PL.
Suppression of atherogenesis by delivery of TGFβ1ACT
using adeno-associated virus type 2 in LDL knockout mice. http://www.athero.org/commentaries/comm532.pdf 2006.
Mehta JL,
Bursac Z, Hauer-Jensen M, Fort C, Fink LM. Comparison of
mortality rates in statin users versus nonstatin users in a
United States veteran population. A J Cardiol 2006; 98(7):923-8.
Mehta JL.
Critical Role of Dyslipidemia and Angiotensin II in Atherogenesis. In: Molecular Mechanisms of Hypertension, Ed. Re R, Schiffrin E, Sowers J, and DiPette D. Taylor & Francis Medical
Books, London, 2006. pp 375-384.
Mehta JL. Oxidized or native
low-density lipoprotein cholesterol: which is more important in
atherogenesis? J Am Coll Cardiol 2006;48(5):980-2.
Editorial.
Mehta
JL, Attramadal H. The TGFbeta superfamily in
cardiovascular biology. Cardiovasc Res 2007;74(2):181-3.
Editorial.
Mehta JL,
Sanada N, Hu CP, Chen J, Dandapat A, Sugawara F, Satoh H, Inoue
K, Kawase Y, Jishage K, Suzuki H, Takeya M, Schnackenberg L,
Beger R, Hermonat PL,
Sawamura T. Deletion of LOX-1
reduces atherogenesis in LDLR knockout mice fed high cholesterol
diet. Circ Res 2007; 100(11):1634-42.
Milstein ML,
McFarland TP, Marsh JD, Cala
SE. Inefficient glycosylation leads
to high steady-state levels of actively degrading cardiac
triadin – 1. Journal of Biological Chemistry 2008;
283(4):1929-35.
Mohandas
B, Singh B, Mehta JL, Sachdeva R. A man with four coronary
arteries. Eur Heart J 2007; 28(11):1357.
Molavi B,
Mehta JL. Oxidative stress in cardiovascular disease:
molecular basis of its deleterious effects, its detection, and
therapeutic considerations. Current Opinion in Cardiology
2004;19:488-493.
Molavi B, Mehta JL:
Cardioprotective effects of Rosiglitazone against
ischemia-reperfusion injury are associated with modulation of
angiotensin receptor expression and signaling. Journal of the
American College of Cardiology 2004; 5: 305.
Molavi B, Rasouli N, Kern PA. The prevention and treatment of metabolic
syndrome and high-risk obesity. Curr Opin Cardiol 2006;
21(5):479-85.
Molavi B,
Chen J, Mehta JL. Cardioprotective effects of
rosiglitazone are associated with selective overexpression of
type 2 angiotensin receptors and inhibition of p42/44 MAPK.
American Journal of Physiology: Heart Circ Physiol 2006;
291(2):H687-93.
Molavi B, Bagwe
S, Mehta JL. Obesity and glucose intolerance is associated with
diastolic dysfunction. Exposing the Achilles heel of early
diabetic cardiomyopathy. Southern Society for Clinical
Investigation meetings, New Orleans, LA, February, 2007;50:S195a.
Muscoli C, Sacco I, Alecce W, Palma
E, Nistico R, Costa N, Clementi F, Rotiroti D,
Romeo F, Salvemini D,
Mehta JL, Mollace V. The
protective effect of superoxide dismutase mimetic M40401 on
balloon injury-related neointima formation: role of the lectin-like
oxidized low-density lipo-protein receptor-1. Journal of
Pharmacology and Experimental Therapeutics 2004; 311:44-50.
Nassief A,
Marsh JD. Statin therapy for stroke prevention.
Stroke 2008; 39(3): 1042-8.
Novelli G, Borgiani P, Mango R,
Romeo F, Mehta JL. OLR1 gene and coronary
artery disease/acute myocardial infarction: replication in an
independently collected sample. Eur J Hum Genet 2006.
14(8):894-5. Letter to Editor.
Quindry J, French J, Hamilton K, Lee Y,
Mehta JL, Powers S. Exercise training provides
cardioprotection against ischemia–reperfusion induced apoptosis
in young and old animals. Experimental Gerontology 2005;
40:416-25.
Rajamani K,
Sunbulli M, Jacobs BS, Berlow E, Marsh
JD, Kronenberg M, McLaughlin P, Vouyouka A, Levine
SR, Lai Z, Chaturvedi S. Detection of carotid stenosis in
African Americans with ischemic heart disease. Journal of
Vascular Surgery 43(6): 1162-1165, 2006.
Ram ML, Kiarash
A, Marsh JD, Cala SE.
Phosphorylation and dephosphorylation of calsequestrin on
CK2-sensitive sites in heart. Mol Cell Biochem 2004;
266:209-217.
Ramappa P, Thatai D, Coplin W,
Gellman S, Carhuapoma JR, Quah R, Atkinson B,
Marsh JD. Cardiac Troponin-I: A
predictor of prognosis in subarachnoid hemorrhage. Journal of Neurocritical Care
2007; December 18 [Epub ahead of print].
Rasouli N,
Molavi B, Elbein SC, Kern PA. Ectopic fat accumulation and
metabolic syndrome. Diabetes Obes Metab 2007;9(1):1-10.
Ridker PM, Brown NJ, Harrison DG,
Mehta JL, Vaughn DE.
Established and emerging plasma biomarkers in the prediction of
first atherothrombotic event. Circulation 2004: 109 (25
Suppl 1):IV6-IV19.
Robinson E,
Bissett J, Smith ES. Amiodarone
toxicity and surveillance. J Ark Med Soc 2005; 101:308-9.
Romeo F, Leo
R, Clementi F, Razzini C, Borzi M, Martuscelli E, Pizzuto F,
Chiricolo G, Mehta JL. Multislice computed tomography in
an asymptomatic high-risk population. Am J Cardiol 2007; 99(3):325-8.
Rossi NF, Black SM,
Télémaque-Potts
S and Chen H.
Neuronal nitric oxide synthase activity in paraventricular
nucleus buffers central ET-1-induced pressor response and AVP
secretion. J Cardiovasc Pharmacol 2004; 44 (suppl 1):
S283-8.
Sabatine MS, Cannon CP, Gibson CM, et al for the CLARITY-TIMI 28
investigators Aude YW,
listed in Appendix). Addition of clopidogrel to aspirin and
fibrinolytic therapy for myocardial infarction with ST-segment
elevation. N Engl J Med 2005;352:1179-89.
Sarkar K, Mehta JL.
Apoptosis in atherosclerosis:
Virtue or Vice. Current Cardiology Review
2005,1:141-152.
Sarkar K,
Sinha A,
Mehta JL.
The role of statins in endothelial dysfunction in
hypertension. Current Opinion in Cardiology.
2006;21:316-21.
Sarkar K,
Sharma SK, Sachdeva R,
Romeo F,
Garza L, Mehta JL. Coronary
artery restenosis: vascular biology and emerging therapeutic
strategies. Expert Rev Cardiovasc Ther 2006; 4(4):543-56.
Sarkar K,
Sinha AK, Mehta JL. The role of statins in endothelial
dysfunction in hypertension.
Curr Opin Cardiol 2006; 21(4):316-21.
Sachdeva R, Sarkar K, Sureddi RK. Myocardial ischemia due to kinking of left
internal mammary artery graft with the expiratory phase of
respiration. J Invasive Cardiol 2007; 19(5):241-2.
Saucedo JF, Garza L, Wolford
DC, Cook SL, Ramanathan KB, Matin Z, McGrew FA, Jacoski MV,
Jennings LK. Tennessee-Arkansas-Mississippi (TAM) Clinical
Research Consortium. Comparative pharmacodynamic evaluation of
eptifibatide and tirofiban HCl in patients undergoing
percutaneous coronary intervention (the TAM1 Study). [Clinical
Trial. Journal Article. Multicenter Study. Randomized Controlled
Trial] American Journal of Cardiology 2004; 93:1279-82.
Saucedo JF, Lui HK, Garza L,
Guerra J, Jacoski MV, Jennings LK. Comparative
pharmacodynamic evaluation of Eptifibitide and Abciximab in
patients with Non_ST segment elevation acute coronary syndromes.
The TAM 2 Study. Journal of Thrombosis and Thrombolysis
2004; 18: 67-74.
Saucedo JF,
Aude YW, Garza L.
Pharmacodynamic evaluation of Bivalirrubin and Clopidogrel with
or without Integrilin: Results of a randomized study. Am J
Cardiol 2005;95:1453-6.
Saucedo JF, Aude YW, Pacheco
R, Thorn B, Matin Z, Husain K, Garza L.
Inhibition of platelet aggregation with Eptifibatide,
Bivalirudin, and Heparin in patients undergoing Percutaneous
Coronary Intervention receiving Clopidogrel pre-Treatment. (The
Pharmaco-Dynamic Evaluation of Angiomax, Clopidogrel With Or
Without INtegrilin [DEACON] Study). American Journal of
Cardiology 2005; 95:1453-1456.
Schror K, Mehta P,
Mehta JL.
Cardiovascular risk of selective COX-2 inhibitors (Editorial).
Journal of Cardiovascular Pharmacology and Therapeutics 2005;10:95-101.
Sepulveda JL, Mehta JL.
C-reactive protein and cardiovascular disease: a critical
appraisal. Current Opinion in Cardiology 2005; 20:407-16.
Shen YH, Utama B, Wang J, Gan Y, Wang X, Wang J, Vercellotti
GM, LeMaire SA, Coselli JS, Mehta JL,
Wang XL. Human cytomegalovirus inhibits Akt-mediated eNOS
activation through upregulating PTEN (phosphatase and tensin
homolog deleted on chromosome 10). Cardiovascular Research
2006;69:502-11.
Sinha AK,
Mehta JL. Modulation of
atherosclerosis, blood pressure and arterial elasticity by
statins.
In: Atherosclerosis, Large Arteries and Cardiovascular Risk,
edited by ME Safar and ED Frohlich, A Volume in the series Advances
in Cardiology. S. Karger AG, Basel, Switzerland. 2006.
Sinha AK,
Mehta JL. Modulation of atherosclerosis, blood pressure and arterial
elasticity by statins. Advanced Cardiology 2007;44:315-30.
Sonkusare S,
Fraer M, Marsh JD, Rusch NJ. Disrupting calcium channel
expression to lower blood pressure: new targeting of a
well-known channel. Mol Interv 2006; 6(6)304-10.
Sonkusare S, Palade PT, Marsh JD,
Télémaque S, Pesic A and Rusch NJ. Vascular calcium
channels and high blood pressure: pathophysiology and
therapeutic implications. Vasc Pharmacol
2006;44:131-42.
Sonkusare S, Stimers JR, Grain T, Marsh
JD, Télémaque S.
Expression of beta2 subunit mutants alters calcium
currents in HL-1 cells. FASEB J 2006; 2 (5, Part II): A1114.
Sukhija R,
Aronow WS, Kakar P, Garza L, Sachdeva R, Sinha A,
Mehta JL. Relation of microalbuminuria and coronary artery
disease in patients with and without diabetes mellitus. Am J Cardiol
2006; Aug 1;98(3):279-81.
Sukhija R,
Kakar P, Mehta V, Mehta JL. Enhanced 11beta-hydroxysteroid dehydrogenase activity, the metabolic syndrome, and systemic
hypertension. Am J Cardiol 2006; Aug 15;98(4):544-8.
Sukhija R, Bursac Z, Mohandas B,
Sachdeva R, Garza L, Aude W,
Sinha A,
Mehta JL. Effect of
3-hydroxy-3-methylglutaryl-CoA reductase inhibitors (statins) on
renal function. American Heart Association Scientific Sessions
2006 Annual Meeting, November 12-15, Chicago, IL. Circ. 2006;
114:II-906a.
Sukhija
R, Eigenbrodt M,
Rose K, Coupe D, Brancati F,
Mehta JL. common
carotid artery diameter is a predictor of myocardial infarction
in middle-aged women. American Heart Association Scientific
Sessions 2006 Annual Meeting, November 12-15, Chicago, IL. Circ.
2006; 114: II-825a.
Sukhija R, Aronow W, Kakar P,
Sachdeva R, Garza L,
Sinha A,
Mehta JL. Microalbuminuria is
Associated With Severe Angiographic Coronary Artery Disease in
Diabetics and Non-Diabetics. Journal of the American
College of Cardiology 2006;47:358A.
Sukhija R, Bursac Z,
Mehta JL.
Effect of 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors on
fasting blood sugar.
Southern
Society for Clinical Investigation meetings, New Orleans, LA,
February, 2007;50:S211a.
Sukhija R,
Fahdi I, Garza L, Fink L, Scott M,
Aude W,
Pacheco
R, Bursac Z, Grant A, Mehta JL. Inflammatory markers,
angiographic severity of coronary artery disease, and patient
outcome. Am J Cardiol 2007; Apr 1;99(7):879-84.
Sukhija R,
Mehta V, Leonardi M, Mehta JL. Implantable cardioverter
defibrillators for prevention of sudden cardiac death. Clin
Cardiol 2007; 30(1):3-8.
Sukhija
R, Bursac Z,
Mehta JL.
Effect of 3-hydroxy-3-methylglutaryl-CoA
reductase inhibitors on fasting blood sugar.
Southern Society for Clinical Investigation
meetings, New Orleans, LA, February, 2007;50:S211a.
Sullivan DH,
Roberson PK, Smith ES, Price JA, Bopp MM. Effects of
muscle strength training and megestrol acetate on strength,
muscle mass, and function in frail older people. J Am Geriatr
Soc 2007; 55(1):20-8.
Telemaque S. and Wang Z.
Identification of target proteins for neuronal calcium sensor-1
(NCS-1) in the heart. Circulation 2006; 114(18):II-93.
Telemaque S,
Liu DS, Grain T, Liu M-Y, Liu SJ. Overexpression of neuronal
calcium sensor-1 alters contractile function in adult rat
ventricular myocytes. FASEB J 2006; 20(5, Part II): A1446.
Telemaque S, Mehta JL. Sepsis,
calcineurin, and cardiac dysfunction: the saga of life and
death. J Am Coll Cardiol 2007; Jan 30;49(4):500-1.
Editorial.
Telemaque
S, Sonkusare S, Grain T,
Rhee SW, Stimers JR, Rusch NJ,
Marsh JD. Design of mutant b2
subunits as decoy
molecules to reduce the expression of functional Ca2+
channels in cardiac cells. Journal of Pharmacology and
Experimental Therapeutics 2008; 325 (1)37-46.
Trigwell S, De S, Sharma R, Mazumder MK, and
Mehta JL. Structural
evaluation of radially expandable cardiovascular stents encased
in a polyurethane film. Journal of Biomedical Materials Research B
Applied Biomaterials 2006; 76(2):241-50.
Viswamitra
S, Higgins CB, Meacham DF,
Mehta JL. Magnetic resonance imaging in myocardial
ischemia. Current Opinion in Cardiology 2004; 19:510-516.
Wang H, Mehta JL, Chen K,
Zhang X, Li DY. Human urotensin II modulates collagen synthesis
and the expression of MMP-1 in human endothelial cells. Journal
of Cardiovascular Pharmacology 2004; 44:577-81.
You H, Liu Y, Prasad CP, Agrawal N, Zhang D, Bandyopadhyay S,
Liu H, Kay HH, Mehta JL, Hermonat PL.
Multiple human papillomavirus genes affect the adeno-associated
virus life cycle.Virology 2005; 344(2):532-40.
You H, LiuY,
Cong M, Ping W, You C, Zhang D, Mehta JL, Hermonat
PL.
HBV genes induce cytotoxic T-lymphocyte response upon adeno-associated
virus (AAV) vector delivery into dendritic cells. J
Viral Hepat 2006; 13(9):605-12.
You H, Liu, Y, Cong M, You CX,
Mehta JL, Hermonat, PL.
HBV genes induce cytotoxic T lymphocyte response upon
adeno-associated virus (AAV) vector delivery into dendritic
cells,
Journal of Viral Hepatitis 2006; 13(9): 605-12.
Zhang W, Li D,
Mehta JL. Role of AIF in human
coronary artery endothelial cell apoptosis. American Journal of
Physiology 2004; 286:H354-8.
|